‘Doses approved by US regulators…’: Centre on vaccines, Remdesivir use | Covid
Published on Apr 13, 2021 07:40 pm IST
- The Centre on Tuesday said doctors should ensure "rational and judicious" use of anti-viral drug Remdesivir, underlining it is to be given only to serious COVID-19 patients in hospitals and is not to be used in home settings. NITI Aayog member (Health) Dr V K Paul said, "Remdesivir is to be used only in those who require hospitalisation and are on oxygen support. That is the precondition. There is no question of its use in the home setting and for mild cases, and it is not to be procured from chemist shops." "We appeal to physicians to ensure rational, correct and judicious use of Remdesivir in hospitalised patients," he said. Watch the full video for more details.
RELATED VIDEOS
India Silently Rushes Warships Near Houthi Territory After U.S. Forms Red Sea Force | Watch
Published on Dec 19, 2023 08:38 pm IST
India calls-out W.H.O Covid death data at Geneva; conveys ‘disappointment’
Published on May 24, 2022 07:41 am IST
Paid Covid booster doses for Indian adults: Prices, Availability | Key details
Published on Jul 25, 2023 03:21 pm IST
How Shanghai is grappling with biggest-ever Covid outbreak
Published on Apr 06, 2022 11:08 pm IST
XE a ‘recombinant’: What we know of the new Covid variant reported from Mumbai
Published on Apr 06, 2022 09:56 pm IST
PM Modi clarifies on migrant crisis; says, ‘States imposed lockdown first’
Published on Feb 10, 2022 09:08 am IST
Hi, {{name}}
Sign out
{{planName}}
{{^userSubscribed}}
{{/userSubscribed}}